Brief: Biogen Q1 Adjusted EPS USD 3.57 Vs. IBES Estimate USD 2.77
29/04/2026 11:10
Apr 29 (Reuters) - Biogen Q1 revenue USD 2,500 million vs. IBES estimate USD 2,255 million. Q1 EPS USD 2.15 outlook FY adjusted EPS USD 14.25-15.25 vs. IBES estimate USD 15
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova